These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [On the pharmacology of the active substances of betel. 1. Central effect of arecoline]. Nieschulz O Arzneimittelforschung; 1967 Oct; 17(10):1292-7. PubMed ID: 5632880 [No Abstract] [Full Text] [Related]
23. [Effect of new pyrazolo-(1,2-a)-1,2,5-triazepine derivatives on the central nervous system]. Szadowska A; Mazur M; Kamińska A; Kusowska J; Winer A Acta Pol Pharm; 1982; 39(5-6):463-67. PubMed ID: 7171016 [No Abstract] [Full Text] [Related]
24. [Comparative characteristics of sodium gamma-hydroxybutyrate, several of its beta-substituted analogs and sodium alpha-hydroxyglutarate]. Uspenskiĭ EA; Listvina VP; Tsybina NM Farmakol Toksikol; 1973; 36(2):185-91. PubMed ID: 4365014 [No Abstract] [Full Text] [Related]
25. [Experimental study of the neurotropic activity of lithium oxybutyrate]. Liubimov BI; Tolmacheva NS; Ostrovskaia RU; Mitrofanov VS Farmakol Toksikol; 1980; 43(3):273-6. PubMed ID: 7449964 [TBL] [Abstract][Full Text] [Related]
26. [Effect of 3-indolylacetylaminorhodanine on the central nervous system of albino rats]. Nevelichuk VV Farmakol Toksikol; 1967; 30(4):401-2. PubMed ID: 5598886 [No Abstract] [Full Text] [Related]
30. [To the pharmacology of the alkaloid eburnamonine]. Trutneva EA; Berezhinskaia VV Farmakol Toksikol; 1966; 29(2):171-5. PubMed ID: 6000339 [No Abstract] [Full Text] [Related]
31. [Comparison of the characteristics of the effect of tranquilizing agents under experimental and clinical conditions]. Vikhliaev IuI; Klygul' TA; Prokudin VN; Adronati SA Farmakol Toksikol; 1971; 34(1):30-5. PubMed ID: 5563373 [No Abstract] [Full Text] [Related]
32. [Animal experimental comparison of tranquilizing effect of doxepine with known psychopharmaceuticals]. Wohlfarth-Ribbentrop A; Schaumann W Arzneimittelforschung; 1969 Dec; 19(12):2012-5. PubMed ID: 5395895 [No Abstract] [Full Text] [Related]
34. [Pharmacological properties of aminoenanthylic acid]. Gofman SM Farmakol Toksikol; 1968; 31(2):188-9. PubMed ID: 4386316 [No Abstract] [Full Text] [Related]
35. Pharmacological studies of Panax Ginseng leaves. Saito H; Morita M; Takagi K Jpn J Pharmacol; 1973 Feb; 23(1):43-56. PubMed ID: 4541617 [No Abstract] [Full Text] [Related]
36. [The action of isoprothane in combination with amidopyrine]. Zorian EV Farmakol Toksikol; 1970; 33(5):518-21. PubMed ID: 5493211 [No Abstract] [Full Text] [Related]
37. Pharmacological properties of Su-19789B, a unique central nervous system stimulant. Chernov HI; Wilson DE; Partyka DA; Bernard PS; Huebner CF Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):34-44. PubMed ID: 4393633 [No Abstract] [Full Text] [Related]
38. [Relation between anticorazol and antiamidopyrine effect of minor tranquilizing agents]. Kuzina NV Farmakol Toksikol; 1970; 33(2):159-63. PubMed ID: 4393232 [No Abstract] [Full Text] [Related]
39. On the central action of some oxoindole compounds. Pelczarska A Arch Immunol Ther Exp (Warsz); 1969; 17(1):118-24. PubMed ID: 5812911 [No Abstract] [Full Text] [Related]
40. Structure-activity relationships within the class of 1,4-benzodiazepines: presence of chlorine and central nervous system activities. De Angelis L; Traversa U; Vertua R Curr Ther Res Clin Exp; 1974 Apr; 16(4):324-37. PubMed ID: 4208349 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]